Thyroid follicular cell function after non-lethal complement membrane attack.
Terminal complement complexes have been identified around thyroid follicles in Graves' disease and Hashimoto's thyroiditis, and the concentrations of such complexes are increased in the sera of these patients, suggesting a role for complement activation and membrane attack complexes (MAC) in autoimmune thyroiditis. This has been investigated further using cultured human and rat thyroid cells. Thyrocytes were resistant to lysis by homologous complement, in contrast to the effects of heterologous (rabbit) complement. The formation of non-lethal amounts of MAC, using reactive lysis or classical pathway activation, significantly reduced cAMP production by these cells in response to thyroid-stimulating hormone (TSH) (P less than 0.01); similar effects were seen with thyroid-stimulating antibodies. Thyroid cells were able to recover rapidly from complement attack after washing and incubation for 30 min. Non-lethal MAC formation also resulted in reactive oxygen metabolite production, detected by luminol-dependent chemiluminescence in three out of five thyroid cell preparations tested. Ionomycin, but not TSH, also stimulated reactive oxygen metabolite production. These results suggest that repeated or continuous sub-lethal complement attack on thyroid cells may exacerbate hypothyroidism in Hashimoto's thyroiditis, or partially counter the effects of thyroid-stimulating antibodies in Graves' disease. Furthermore, the production of reactive oxygen metabolites in these circumstances could increase the intra-thyroidal inflammatory response; oxygen radical scavenging by anti-thyroid drugs (which are concentrated by thyrocytes) may account in part for the amelioration of thyroiditis observed with such treatment.
Weetman
A P
AP
Department of Medicine, University of Cambridge Clinical School, England, UK.
Freeman
M
M
Morgan
B P
BP
D000818:Animals; D002460:Cell Line; D002470:Cell Survival; D002478:Cells, Cultured; D003167:Complement Activation; D015938:Complement Membrane Attack Complex / Q000276:immunology*; D000242:Cyclic AMP / Q000096:biosynthesis; D006111:Graves Disease / Q000276:immunology; D006801:Humans; D010101:Oxygen Consumption; D051381:Rats; D013961:Thyroid Gland / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D013972:Thyrotropin / Q000494:pharmacology
D015938:Complement Membrane Attack Complex; D013972:Thyrotropin; D000242:Cyclic AMP